Similar articles

• [Drug therapy of intractable Mycobacterium infections].

  Kuze F. Kuze F. Nihon Naika Gakkai Zasshi. 1990 Dec 10;79(12):1674-9. Nihon Naika Gakkai Zasshi. 1990. PMID: 2079590 Japanese. No abstract available.
• The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.

  Waller EA, Roy A, Brumble L, Khoor A, Johnson MM, Garland JL. Waller EA, et al. Chest. 2006 Oct;130(4):1234-41. doi: 10.1378/chest.130.4.1234. Chest. 2006. PMID: 17035461
• [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].

  Tsukamura M. Tsukamura M. Kekkaku. 1989 Aug;64(8):511-8. Kekkaku. 1989. PMID: 2811008 Japanese.
• Diagnosis and treatment of infections due to Mycobacterium avium complex.

  Kasperbauer SH, Daley CL. Kasperbauer SH, et al. Semin Respir Crit Care Med. 2008 Oct;29(5):569-76. doi: 10.1055/s-0028-1085708. Epub 2008 Sep 22. Semin Respir Crit Care Med. 2008. PMID: 18810690 Review.
• Lung disease caused by nontuberculous mycobacteria.

  Alvarez-Uria G. Alvarez-Uria G. Curr Opin Pulm Med. 2010 May;16(3):251-6. doi: 10.1097/MCP.0b013e3283378fa3. Curr Opin Pulm Med. 2010. PMID: 20154623 Review.